arrow
P

Piyada Sitthideatphaiboon

chulalongkorn university and the king chulalongkorn memorial hospital
H指数:10
被引数:621

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in the Thai population: a real-world; multicenter observational study

度鲁木单抗在泰国人群III期非小细胞肺癌患者中完成根治性放化疗后的应用:一项真实世界、多中心观察性研究

2025-10-220
OAAI
Savolitinib Plus Osimertinib in Epidermal Growth Factor-Mutated, MET-Amplified Advanced Non-Small Cell Lung Cancer: A Randomized Phase 2 trial

Savolitinib 联合 Osimertinib 治疗表皮生长因子突变、MET 扩增的晚期非小细胞肺癌:一项随机 II 期临床试验

2025-10-220
PRE
Long-term impact of anthracycline in early-stage breast cancer, bridging of MiRNAs profiler for early cardiotoxicity

早期乳腺癌中蒽环类药物的长期影响,miRNA表达谱桥接早期心脏毒性

2025-04-230
OA
Presence of liver metastasis correlated with high tumor abundance and indicated adverse prognostic feature in EGFR mutation non-small-cell lung cancer patients

在EGFR突变的非小细胞肺癌患者中,肝转移的存在与高肿瘤丰度相关,并表明不良预后特征

2025-01-020
OAAI
Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC)

泰国晚期非小细胞肺癌 (NSCLC) 患者对免疫疗法的饮食模式和相应的肠道微生物组

2024-11-131
OAAI
Efficacy of lower dose of dexamethasone premedication in patient receiving docetaxel-based chemotherapy in preventing hypersensitivity reaction: A randomized controlled trial

地塞米松低剂量预处理的疗效:在预防接受多西他赛为基础的化疗患者发生超敏反应中的研究——一项随机对照试验

2024-09-010
PRE
Savolitinib (savo) plus osimertinib (osi) vs savo plus placebo (PBO) in patients (pts) with EGFR-mutated (EGFRm), MET-amplified advanced NSCLC with progression on osi
2024-04-050
PRE
Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study
2022-10-018
OAAI